Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) shares dropped 6.7% during mid-day trading on Wednesday . The stock traded as low as $8.00 and last traded at $8.09. Approximately 539,500 shares changed hands during mid-day trading, an increase of 209% from the average daily volume of 174,735 shares. The stock had previously closed at $8.67.

AVDL has been the topic of several recent research reports. Ladenburg Thalmann Financial Services raised their target price on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from $27.00 to $30.00 in a research note on Thursday, September 7th. Langenberg & Company reaffirmed a “buy” rating and issued a $30.00 target price (up previously from $27.00) on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share in a research note on Thursday, September 7th. Roth Capital set a $15.00 target price on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share and gave the company a “buy” rating in a research note on Wednesday, August 9th. Finally, Zacks Investment Research raised shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a “sell” rating to a “hold” rating in a research note on Tuesday, November 14th.

The company has a market cap of $347.53, a P/E ratio of 16.06 and a beta of 1.34. The company has a current ratio of 1.53, a quick ratio of 1.47 and a debt-to-equity ratio of 0.01.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) last released its quarterly earnings data on Wednesday, November 8th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.13. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share had a net margin of 44.47% and a return on equity of 33.92%. The business had revenue of $39.68 million for the quarter, compared to analyst estimates of $38.22 million. During the same quarter last year, the firm earned ($0.08) EPS. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share’s quarterly revenue was up 23.7% compared to the same quarter last year. equities analysts forecast that Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share will post 0.28 EPS for the current year.

In other news, CEO Michael S. Anderson acquired 4,000 shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share stock in a transaction that occurred on Tuesday, September 12th. The shares were acquired at an average price of $9.80 per share, with a total value of $39,200.00. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Greg J. Divis acquired 10,600 shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share stock in a transaction that occurred on Tuesday, September 12th. The shares were purchased at an average cost of $9.32 per share, for a total transaction of $98,792.00. Following the purchase, the insider now directly owns 10,600 shares in the company, valued at $98,792. The disclosure for this purchase can be found here. Insiders have purchased a total of 46,855 shares of company stock worth $445,058 in the last three months. 5.07% of the stock is owned by insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Stifel Financial Corp boosted its stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 4.3% during the 2nd quarter. Stifel Financial Corp now owns 60,500 shares of the company’s stock worth $667,000 after acquiring an additional 2,500 shares during the last quarter. Citadel Advisors LLC bought a new position in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 2nd quarter worth approximately $354,000. Virtu KCG Holdings LLC bought a new position in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 2nd quarter worth approximately $259,000. JPMorgan Chase & Co. bought a new position in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share during the 2nd quarter worth approximately $733,000. Finally, GSA Capital Partners LLP boosted its stake in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 9.9% during the 2nd quarter. GSA Capital Partners LLP now owns 200,213 shares of the company’s stock worth $2,208,000 after acquiring an additional 18,056 shares during the last quarter. 67.81% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (AVDL) Stock Price Down 6.7%” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/06/avadel-pharmaceuticals-plc-american-depositary-shares-each-representing-one-ordinary-share-avdl-stock-price-down-6-7.html.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share Company Profile

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to commercialize differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results.

Receive News & Stock Ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share and related stocks with our FREE daily email newsletter.